Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: A pediatric oncology group study

Neyssa M. Marina, Debon Cochrane, Elaine Harney, Katie Zomorodi, Susan Blaney, Naomi Winick, Mark Bernstein, Michael P. Link

Research output: Contribution to journalArticlepeer-review

92 Scopus citations

Fingerprint

Dive into the research topics of 'Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: A pediatric oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences